{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:09:12Z","timestamp":1761750552763,"version":"build-2065373602"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"36","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>This network meta-analysis (NMA) aims to compare the relative efficacy of oral Chinese patent medicine combined with transarterial chemoembolization (TACE) for treating hepatocellular carcinoma (HCC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Databases, including China National Knowledge Infrastructure, Wanfang, Weipu, PubMed, Embase, Web of Science, and Cochrane Central Register of Controlled Trials (CENTRAL), were accessed from inception to the present to collect randomized controlled trials of different oral Chinese patent medicines (OCPMs). Objective response rate, 1-year survival rate, lymphocytes, nausea and vomiting were used as efficacy or tolerability outcomes. A Bayesian NMA was performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Seventy-five randomized controlled trials involving 6912 participants and 9 OCPMs were included. The results of the NMA showed that the comparisons were all indirect. The NMA demonstrated that, regarding the objective response rate, TACE combined with all OCPMs showed the advantages over TACE monotherapy, of which Cidan capsule (odds ratio [OR] 3.5, 95% credible interval 2.3\u20134.9) was the most effective treatment. Among 9 OCPMs, Cidan capsule was the most effective for survival improvement (OR 5.1, 95% CrI 2.7\u20138.7).\u201c Jinlong for immune function (OR 0.35, 95% CrI 0.14\u20130.57), and Shenyi for adverse event reduction (OR 0.39, 95% CrI: 0.18\u20130.87).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>OCPMs have significant efficacy in treating HCC combined with TACE. Cidan, Jinlong, and Shenyi capsules might be the optimum drugs for HCC adjuvant therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000044332","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T18:00:23Z","timestamp":1757354423000},"page":"e44332","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Oral Chinese patent medicine combined with transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: A Bayesian network meta-analysis"],"prefix":"10.1097","volume":"104","author":[{"given":"Shan","family":"Ji","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Hepatology IV, Beijing You\u2019an Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0805-5740","authenticated-orcid":false,"given":"Xiaojun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Integrated Traditional Chinese and Western Medicine, Beijing You\u2019an Hospital, Capital Medical University, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20251029","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma.","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20251029","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma.","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med"},{"key":"R3-20251029","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ctrv.2018.11.002","article-title":"Updated use of TACE for hepatocellular carcinoma treatment: how and when to use it based on clinical evidence.","volume":"72","author":"Raoul","year":"2019","journal-title":"Cancer Treat Rev"},{"key":"R4-20251029","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1186\/s12885-021-08253-1","article-title":"Mechanism and risk factors of nausea and vomiting after TACE: a retrospective analysis.","volume":"21","author":"Lu","year":"2021","journal-title":"BMC Cancer"},{"key":"R5-20251029","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1089\/acm.2008.0060","article-title":"Traditional Chinese medicine plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma.","volume":"14","author":"Meng","year":"2008","journal-title":"J Altern Complement Med"},{"key":"R6-20251029","doi-asserted-by":"crossref","first-page":"153575","DOI":"10.1016\/j.phymed.2021.153575","article-title":"Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT\/CyclinD1\/p21\/p27 pathway.","volume":"87","author":"Yang","year":"2021","journal-title":"Phytomedicine"},{"key":"R7-20251029","doi-asserted-by":"crossref","first-page":"152930","DOI":"10.1016\/j.phymed.2019.152930","article-title":"Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma.","volume":"62","author":"Liu","year":"2019","journal-title":"Phytomedicine"},{"key":"R8-20251029","first-page":"3053","article-title":"Oral Chinese Medicine for the treatment of targeted therapy-induced diarrhea: a systematic review and meta-analysis.","volume":"27","author":"Liu","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R9-20251029","doi-asserted-by":"crossref","first-page":"1106827","DOI":"10.3389\/fonc.2023.1106827","article-title":"Adjuvant effect of herbal medicine on transarterial chemoembolization in patients with hepatocellular carcinoma: a systematic review and meta-analysis.","volume":"13","author":"Oh","year":"2023","journal-title":"Front Oncol"},{"key":"R10-20251029","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11655-022-3537-4","article-title":"Cidan capsule in combination with adjuvant transarterial chemoembolization reduces recurrence rate after curative resection of hepatocellular carcinoma: a multicenter, randomized controlled trial.","volume":"29","author":"Zheng","year":"2023","journal-title":"Chin J Integr Med"},{"key":"R11-20251029","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.3892\/etm.2015.2351","article-title":"Cidan inhibits liver cancer cell growth by reducing COX-2 and VEGF expression and cell cycle arrest.","volume":"9","author":"Li","year":"2015","journal-title":"Exp Ther Med"},{"key":"R12-20251029","doi-asserted-by":"crossref","first-page":"e202301468","DOI":"10.1002\/cbdv.202301468","article-title":"Comprehensive review on herbal medicine: emphasis on current therapy and role of phytoconstituents for cancer treatment.","volume":"21","author":"Sharma","year":"2024","journal-title":"Chem Biodivers"},{"key":"R13-20251029","doi-asserted-by":"crossref","first-page":"15347354231226256","DOI":"10.1177\/15347354231226256","article-title":"Comprehensive evaluation of traditional herbal medicine combined with adjuvant chemotherapy on post-surgical gastric cancer: a systematic review and meta-analysis.","volume":"23","author":"Kim","year":"2024","journal-title":"Integr Cancer Ther"},{"key":"R14-20251029","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s11655-022-3465-3","article-title":"Treatment of lung cancer with orally administered Chinese herbal medicine: an evidence map between 1970-2020.","volume":"28","author":"Gui","year":"2022","journal-title":"Chin J Integr Med"},{"key":"R15-20251029","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1142\/S0192415X20500780","article-title":"Positive role of Chinese herbal medicine in cancer immune regulation.","volume":"48","author":"Wang","year":"2020","journal-title":"Am J Chin Med"},{"key":"R16-20251029","doi-asserted-by":"crossref","first-page":"155488","DOI":"10.1016\/j.phymed.2024.155488","article-title":"The antitumor effects of herbal medicine Triphala on oral cancer by inactivating PI3K\/Akt signaling pathway: based on the network pharmacology, molecular docking, in vitro and in vivo experimental validation.","volume":"128","author":"Hu","year":"2024","journal-title":"Phytomedicine"},{"key":"R17-20251029","doi-asserted-by":"crossref","first-page":"609705","DOI":"10.3389\/fimmu.2020.609705","article-title":"Research status and molecular mechanism of the traditional Chinese medicine and antitumor therapy combined strategy based on tumor microenvironment.","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"R18-20251029","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.7150\/thno.43622","article-title":"Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription.","volume":"10","author":"Zou","year":"2020","journal-title":"Theranostics"},{"key":"R19-20251029","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/ACO.0b013e32835956d8","article-title":"Nausea and vomiting after surgery: it is not just postoperative.","volume":"25","author":"Lichtor","year":"2012","journal-title":"Curr Opin Anaesthesiol"},{"key":"R20-20251029","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.gastro.2006.11.002","article-title":"The serotonin signaling system: from basic understanding to drug development for functional GI disorders.","volume":"132","author":"Gershon","year":"2007","journal-title":"Gastroenterology"},{"key":"R21-20251029","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1002\/ptr.7563","article-title":"Medicinal herbs in treating chemotherapy-induced nausea and vomiting: a review.","volume":"36","author":"Rajabalizadeh","year":"2022","journal-title":"Phytother Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044332","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:04:38Z","timestamp":1761750278000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":21,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044332","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2025,9,5]]},"assertion":[{"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}